Asymptomatic CMV infections in long-term renal transplant recipients are associated with the loss of FcRγ from LIR-1+ NK cells

European Journal of Immunology

Volumn 46, Issue 11, 2016, Pages 2597-2608

  Makwana, Nandini B ^a,b   Foley, Bree ^c   Lee, Silvia ^b,d   Fernandez, Sonia ^a   Irish, Ashley B ^e   Price, Patricia ^b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b CURTIN UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e FIONA STANLEY HOSPITAL   (Australia)

Author keywords

CMV; Cytokines; Cytotoxicity; Natural killer cells; Renal transplantation

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; FC RECEPTOR; FFC RECEPTOR GAMMA; GLYCOPROTEIN B; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; PERFORIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GLYCOPROTEIN B, SIMPLEXVIRUS; IMMUNOGLOBULIN RECEPTOR; KLRC2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LILRB1 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C; NCR1 PROTEIN, HUMAN; NCR3 PROTEIN, HUMAN; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

ADULT; AGED; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN ANTIBODY REACTION; ARTICLE; ASYMPTOMATIC INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT RECIPIENT; HUMAN; KIDNEY TRANSPLANTATION; LONG TERM CARE; LYMPHOCYTE FUNCTION; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; VIRUS REACTIVATION; VIRUS REPLICATION; BLOOD; CYTOMEGALOVIRUS; DEFICIENCY; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHENOTYPE; VIROLOGY;

ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ANTIGENS, CD; ASYMPTOMATIC INFECTIONS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; PERFORIN; PHENOTYPE; RECEPTORS, IGG; RECEPTORS, IMMUNOLOGIC; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 84988826418     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646422     Document Type: Article

References (46)

1. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633–640.
2. Middleton, D., Curran, M. and Maxwell, L., Natural killer cells and their receptors. Transplant Immunol. 2002. 10: 147–164.
3. Caligiuri, M. A., Human natural killer cells. Blood 2008. 112: 461–469.
4. Farag, S. S., VanDeusen, J. B., Fehniger, T. A. and Caligiuri, M. A., Biology and clinical impact of human natural killer cells. Int. J. Hematol. 2003. 78: 7–17.
5. Brennan, D. C., Cytomegalovirus in renal transplantation. J. Am. Soc. Nephrol. 2001. 12: 848–855.
6. Kuijpers, T. W., Baars, P. A., Dantin, C., M. van den Burg, M., van Lier, R. A. and Roosnek, E., Human NK cells can control CMV infection in the absence of T cells. Blood 2008. 112: 914–915.
7. Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N. and López-Botet, M., Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. 2004. 104: 3664–3671.
8. Monsivais-Urenda, A., Noyola-Cherpitel, D., Hernandez-Salinas, A., Garcia-Sepulveda, C., Romo, N., Baranda, L. et al., Influence of human cytomegalovirus infection on the NK cell receptor repertoire in children. Eur. J. Immunol. 2010. 40: 1418–1427.
9. Wilkinson, G. W., Tomasec, P., Stanton, R. J., Armstrong, M., Prod'homme, V., Aicheler, R., McSharry, B. P. et al., Modulation of natural killer cells by human cytomegalovirus. J. Clin. Virol. 2008. 41: 206–212.
10. Prod'homme, V., Griffin, C., Aicheler, R. J., Wang, E. C., McSharry, B. P., Rickards, C. R., Stanton, R. J., Borysiewicz, L. K. et al., The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J. Immunol. 2007. 178: 4473–4481.
11. Wagner, C. S., Riise, G. C., Bergstrom, T., Karre, K., Carbone, E. and Berg, L., Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J. Immunol. 2007. 178: 3536–3543.
12. Lopez-Verges, S., Milush, J. M., Schwartz, B. S., Pando, M. J., Jarjoura, J., York, V. A., Houchins, J. P. et al., Expansion of a unique CD57(+)NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2011. 108: 14725–14732.
13. Guma, M., Budt, M., Saez, A., Brckalo, T., Hengel, H., Angulo, A. and Lopez-Botet, M., Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006. 107: 3624–3631.
14. Foley, B., Cooley, S., Verneris, M. R., Pitt, M., Curtsinger, J., Luo, X., Lopez-Verges, S. et al., Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 2012. 119: 2665–2674.
15. Wu, Z., Sinzger, C., Frascaroli, G., Reichel, J., Bayer, C., Wang, L., Schirmbeck, R. et al., Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 2013. 87: 7717–7725.
16. Zhang, T., Scott, J. M., Hwang, I. and Kim, S., Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency. J. Immunol. 2013. 190: 1402–1406.
17. Beziat, V., Dalgard, O., Asselah, T., Halfon, P., Bedossa, P., Boudifa, A., Hervier, B. et al., CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 2012. 42: 447–457.
18. Miyashita, R., Tsuchiya, N., Hikami, K., Kuroki, K., Fukazawa, T., Bijl, M., Kallenberg, C. G. et al., Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 2004. 16: 163–168.
19. Goodier, M. R., White, M. J., Darboe, A., Nielsen, C. M., Goncalves, A., Bottomley, C., Moore, S. E. et al., Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 2014. 124(14): 2213–2222.
20. Muntasell, A., López-Montañés, M., Vera, A., Heredia, G., Romo, N., Peñafiel, J., Moraru, M. et al., NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 2013. 43(12): 3268–3278.
21. Middleton, D., Gonzalez, A. and Gilmore, P. M., Studies on the expression of the deleted KIR2DS4*003 gene product and distribution of KIR2DS4 deleted and nondeleted versions in different populations. Hum. Immunol. 2007. 68: 128–134.
22. Hazeldine, J., Hampson, P. and Lord, J. M., Reduced release and binding of perforin at the immunological synapse underlies the age-related decline in natural killer cell cytotoxicity. Aging Cell 2012. 11: 751–759.
23. Muntasell, A., Pupuleku, A., Cisneros, E., Vera, A., Moraru, M., Vilches, C. and Lopez-Botet, M., Relationship of NKG2C copy number with the distribution of distinct cytomegalovirus-induced adaptive NK cell subsets. J. Immunol. 2016. 196(9): 3818–3827.
24. Wille, P. T., Wisner, T. W., Ryckman, B. and Johnson, D. C., Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein. mBio 2013. 4: e00332–00313.
25. Kinzler, E. R. and Compton, T., Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion. J. Virol. 2005. 79: 7827–7837.
26. Kirchmeier, M., Fluckiger, A. C., Soare, C., Bozic, J., Ontsouka, B., Ahmed, T., Diress, A. et al., Enveloped virus-like particle expression of human cytomegalovirus glycoprotein B antigen induces antibodies with potent and broad neutralizing activity. Clin. Vacc. Immunol. 2014. 21: 174–180.
27. Britt, W. J., Vugler, L., Butfiloski, E. J. and Stephens, E. B., Cell surface expression of human cytomegalovirus (HCMV) gp55-116 : use of HCMV-recombinant vaccinia virus-infected cells in analysis of the human neutralizing antibody response. J. Virol. 1990. 64: 1079–1085.
28. Fouts, A. E., Chan, P., Stephan, J. P., Vandlen, R. and Feierbach, B., Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J. Virol. 2012. 86: 7444–7447.
29. Sun, J. C., Beilke, J. N. and Lanier, L. L., Adaptive immune features of natural killer cells. Nature 2009. 457: 557–561.
30. Chapman, T. L., Heikema, A. P. and Bjorkman, P. J., The inhibitory receptor LIR-1 uses a common binding interaction to recognize Class I MHC molecules and the viral homolog UL18. Immunity 1999. 11: 603–613.
31. Berg, L., Riise, G. C., Cosman, D., Bergström, T., Olofsson, S., Kärre, K. and Carbone, E., LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. The Lancet 2003. 361: 1099–1101.
32. Wagner, C. S., Ljunggren, H. G. and Achour, A., Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J. Immunol. 2008. 180: 19–24.
33. Topham, N. J. and Hewitt, E. W., Natural killer cell cytotoxicity: how do they pull the trigger? Immunology 2009. 128: 7–15.
34. Parry, H. M., Zuo, J., Frumento, G., Mirajkar, N., Inman, C., Edwards, E., Griffiths, M. et al., Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immunity Ageing 2016. 13: 1.
35. + NK-cell subset. Blood 2010. 116: 3865–3874.
36. Solana, R., Tarazona, R., Gayoso, I., Lesur, O., Dupuis, G. and Fulop, T., Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Sem. Immunol. 2012. 24: 331–341.
37. dim NK-cell differentiation uncoupled from NK-cell education. Blood 2010. 116: 3853–3864.
38. Krzewski, K., Gil-Krzewska, A., Nguyen, V., Peruzzi, G. and Coligan, J. E., LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood 2013. 121: 4672–4683.
39. Schlums, H., Cichocki, F., Tesi, B., Theorell, J., Beziat, V., Holmes, T. D., Han, H. et al., Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 2015. 42: 443–456.
40. Foley, B., Cooley, S., Verneris, M. R., Curtsinger, J., Luo, X., Waller, E. K., Anasetti, C. et al., Human cytomegalovirus (CMV)-induced memory-like NKG2C(+) NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 2012. 189: 5082–5088.
41. Courivaud, C., Bamoulid, J., Chalopin, J. M., Gaiffe, E., Tiberghien, P., Saas, P. and Ducloux, D., Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J. Inf. Dis. 2013. 207: 1569–1575.
42. Epstein, S. E., Zhu, J., Najafi, A. H. and Burnett, M. S., Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 2009. 119: 3133–3141.
43. Bolovan-Fritts, C. A. and Spector, S. A., Endothelial damage from cytomegalovirus-specific host immune response can be prevented by targeted disruption of fractalkine-CX(3)CR1 interaction. Blood 2008. 111: 175–182.
44. Rieben, R. and Seebach, J. D., Xenograft rejection: IgG1, complement and NK cells team up to activate and destroy the endothelium. Trends Immunol. 2005. 26: 2–5.
45. + natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus. Arterio Thromb. Vasc. Biol. 2013. 33: 2653–2659.
46. Gkrania-Klotsas, E., Langenberg, C., Sharp, S. J., Luben, R., Khaw, K. T. and Wareham, N. J., Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J. Inf. Dis. 2012. 206: 1897–1903.